综述

肠道病毒71型疫苗的研究进展

  • 周璐 王继麟
展开
  • 430200 武汉生物制品研究所有限责任公司肠道病毒疫苗室

网络出版日期: 2025-08-16

Progress in development of enterovirus 71 vaccines

Expand
  • Enterovirus Vaccine Department, Wuhan Institute of Biological Products Co., Ltd., Wuhan?430200,China

Online published: 2025-08-16

摘要

 肠道病毒71型(enterovirus 71,EV71)是近年来我国流行的手足口病的主要病原体之一,并且由其感染引发的重症和死亡病例的比例较大。目前尚无治疗手足口病的特效药物。我国大陆有3家单位完成了EV71灭活疫苗的Ⅲ期临床试验,国家食品药品监督管理总局批准了其中两家单位的灭活疫苗。目前,减毒活疫苗、病毒样颗粒疫苗、亚单位疫苗和DNA疫苗等已开展动物研究。

本文引用格式

周璐 王继麟 . 肠道病毒71型疫苗的研究进展[J]. 国际生物制品学杂志, 2016 , 39(4) : 167 -170,186 . DOI: 10.3760/cma.j.issn.1673-4211.2016.04.003

Abstract

Enterovirus 71 (EV71) is one major etiological agent of hand, foot and mouth disease, and associated with the majority of severe and death cases. To date, there is no effective therapy for EV71 infection. In mainland China, 3 companies have finished phase 3 trials of inactivated EV71 vaccines, and vaccines from 2 of them were approved by China Food and Drug Administration. Several EV71 vaccine candidates, including live-attenuated, virus-like particle, subunit, and DNA vaccines, have been evaluated in animals.
文章导航

/